Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM
MONDAY, Aug. 26, 2024 (HealthDay News) -- For older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study...